Introduction
Marine biodiscovery is the search for marine natural products with potential economic and societal benefits for use as agrochemicals, cosmetics, anti-fouling agents, nutraceuticals and pharmaceuticals. 1, 2 Generally, marine invertebrates utilise their secondary metabolites or natural products as a form of chemical defence against predators and as a competitive advantage in their perpetual battle for limited resources, such as nutrients and space. 2, 3 Over the past 50 years, marine invertebrates and their associated microorganisms have proved to be an important source of bioactive natural products for the development of new pharmaceuticals, 4,5 especially anti-cancer agents, e.g. Adcetris ® , Halaven ® and Yondelis ® , that were discovered by initially screening for cytotoxic compounds against cancer cell lines. 6, 7 Marine sponges (Phylum: Porifera) have arguably been one of the dominant sources of marine natural products that are utilised commercially for their beneficial pharmacological properties in biomedical research. 6 There currently are seven FDA-approved marine natural products derived drugs, of which four are anti-cancer chemotherapeutic agents, and a further 13 marine-derived agents that are either in human clinical trials or in advanced pre-clinical status, including a synthetic derivative of the South African marine sponge natural product Hemiasterlin. 6, 7 The latest review by Newman and Cragg 8 highlights the significant contribution of natural products research to the field of drug discovery, with an estimated 77% of all anti-cancer drugs approved between 1940 and 2014 being small molecule natural products and natural product-derived compounds.
Southern Africa's marine biota is home to a wealth of biodiversity along the approximately 3000-km coastline of South Africa and around the archipelagos of the Southern Ocean, including the Prince Edward Islands (PEIs) which consist of Marion Island and Prince Edward Island. The biomedicinal potential of southern African marine invertebrates was initially revealed through the marine biodiscovery efforts of Robert Pettit (Arizona State University) and Yoel Kashman (Tel Aviv University). 9, 10 The initial biological screening for cytotoxic compounds and subsequent natural products chemistry work by Pettit and his co-workers on their South African marine collections resulted in the isolation of two very important classes of bioactive compounds known as the cephalostatins and spongiostatins. 9, 10 The cephalostatins and spongiostatins were isolated through cytotoxic activity-directed purification of crude extracts and are well known to be some of the most cytotoxic secondary metabolites (about 1 nM activity) ever to be screened by the United States National Cancer Institute (NCI) against their 60 cancer cell line panel (NCI-60). 9,10 Cephalostatin 1 and its closely related naturally occurring analogues were isolated from aqueous and organic extracts of the South African marine tube worm Cephalodiscus gilchristi, while Spongiostatins 4 and 5 were isolated from the organic extract of the bright orange 'wallsponge' Trachycladus spinispirulifer collected off the southern coasts of South Africa. 9, 10 The collaborative biodiscovery programme in Sodwana Bay between Kashman, the Oceanography Research Institute and the pharmaceutical company PharmaMar involved the primary biological screening of crude extracts for cytotoxic compounds against the P-388, A549, HT-29 and MEL-28 cancer cell lines. This screening resulted in the discovery of 33 new bioactive natural product compounds, mostly isolated from marine sponges, of which 9 compounds were patented for their anti-cancer properties. 9,10 These compounds include two cytotoxic peptides -Hemiasterlin and Geodiamolide TA -isolated from the marine sponge Hemiasterella minor (Kirkpatrick); a synthetic analogue of Hemiasterlin was subsequently developed and has successfully entered phase one of human clinical trials as an anti-cancer drug. 6, 9 Between 1992 and 2012, the marine natural products research groups at Rhodes University, in collaboration with various other scientific research groups and institutes, led the search for, and provided important contributions to, the discovery of novel bioactive natural product compounds from southern African marine organisms. [9] [10] [11] [12] Davies-Coleman and colleagues 13, 14 have previously reported the screening of several extracts of southern African marine invertebrates for anti-oeso phageal cancer activity, including five deep-water sponges collected from the PEIs that were tested against the WHCO1 cell line. The sponges were collected during the 2004 annual relief voyage by the SA Agulhas I. 13 To the best of our knowledge, this report was the first and only report of a multidisciplinary research consortium from exclusively South African institutions (Rhodes University, University of Cape Town and Council for Scientific and Industrial Research), searching for cytotoxic chemical compounds from marine sponges with potential anti-tumour properties from the Southern Ocean. 13 The natural product investigation by Davies-Coleman et al. 13 of the most promising extract was unfortunately hampered by the paucity of the sponge material collected (ca. 200 g), although the amount of crude organic extract derived was not given. As far as we know, a subsequent collection in 2005 has to date not yielded any new and/or bioactive marine natural product compounds.
The relatively unexplored natural product diversity and pharmaceutical potential of marine invertebrates from the sub-Antarctic Islands and Southern Ocean, therefore presents us with an exciting opportunity and we have thus initiated a new multidisciplinary effort by a concerted group of South African institutions to explore the cytotoxic potential of marine sponges from the sub-Antarctic Islands and the Southern Ocean. We report here the cytotoxic activity, against three different cancer cell lines, of both aqueous and organic crude extracts prepared from nine sponge specimens, collected from various depths around the PEIs in the Southern Ocean. From the various benthic dredges, nine sponge specimens were collected, labelled and photographed and the relevant collection information, e.g. GPS coordinates and depths, was recorded. The sponge specimens were placed in sealed bags, immediately frozen on board the research vessel until the end of the journey and transferred after the expedition to a freezer in the Department of Chemistry at the University of Cape Town. Histological and genetic samples (~5-10 cm 3 ) were taken from each specimen for identification and stored in 96% (v/v) ethanol. Vouchers of the sponges are housed in the collection of Dr Toufiek Samaai (Department of Environmental Affairs). All sponge specimens were processed individually in the same manner. A frozen portion (up to 90% of the wet mass) of each sponge was cut into small pieces, frozen in liquid nitrogen and lyophilised until the material was dry. The mass of the dried sponges was recorded and the sponge materials were then subjected to solvent extraction. Both aqueous (100% deionised water) and organic (50:50 mixture of methanol and dichloromethane) crude extracts of the sponges were prepared by following, where possible, the protocol for marine specimens established by scientists at the Developmental Therapeutics Program of the NCI. 15 The resulting 18 crude extracts, one organic (suffix '-1') and one aqueous (suffix '-2') for each sponge, were screened for their cytotoxic activity against the cervical (HeLa ATCC CCL-2), lung (A549 ATCC CCL-185) and breast (MCF7 ATCC HTB-22) cancer cell lines. Cells were cultured in Dulbecco's Modified Eagle's Medium supplemented with 10% (v/v) foetal bovine serum, 2 mM Glutamax and 100 U/mL penicillin/streptomycin/ amphotericin at 37 °C with 9% CO 2 . Sub-culturing was carried out by removing the media, washing with phosphate-buffered saline (10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , 2.7 mM KCl, 140 mM NaCl, pH 7.4) and lifting the cells using a 1% (v/v) trypsin in 0.3% (w/v) ethylenediaminetetraacetic acid (EDTA) solution. Cells were confirmed to be mycoplasma free by microscopy after staining with Hoechst 33342. The chemosensitivity of the cell lines to the extracts was tested using the WST-1 assay. For each extract, 5 x 10 3 cells/well were seeded in a 96-well plate and allowed to sit overnight before being treated in triplicate with the extracts at a range of concentrations (0.1-100 µg/mL). The plates were incubated at 37 °C and 9% CO 2 for 72 h. All the media were removed and 100 µL WST-1 reagent (0.5 mg/mL) was added to each well after the 72-h incubation. The plates were incubated at 37 °C in 9% CO 2 and the absorbance at 450 nm read after 2 h, 4 h and 6 h. For all treatments the half maximum effective concentration (EC 50 ) for data from the reading at 6 h was calculated by non-linear regression using GraphPad Prism version 4.0. Spectroscopic analyses of portions of the crude extracts were acquired using standard pulse sequences on a Bruker 600-MHz nuclear magnetic resonance (NMR) spectrometer, equipped with a 5-mm Prodigy cryoprobe.
Materials and methods

Results
Taxonomic identification of the nine sponge specimens collected revealed eight sponge species (Table 1) as two sponge specimens (MAR15-005 and MAR15-012), collected from two distant geographical locations (Dredge Stations 3 and 1, respectively; Figure 1 ), were identified as the same Halichondria (Halichondria) cf. panicea sponge species. The preliminary biological screening results obtained for the crude extracts are summarised in Table 1 and indicate that only three (MAR15-001, MAR15-005, MAR15-012) of the nine sponge specimens exhibited cytotoxicity against the cancer cell lines tested.
The aqueous extract of the sponge Myxilla (Ectyomyxilla) kerguelensis (MAR15-001-2) displayed cytotoxic activity (EC 50 11.7 µg/mL) against the HeLa cervical cancer cell line ( Table 1) against any of the cancer cell lines. It is also interesting to note that a number of the samples, particularly the organic extracts, induced dose-dependent proliferation in the MCF7 and A549 cell lines (shown by P in Table 1 ).
Proton ( (Figure 2a) . A cursory examination of the 1 H NMR spectra recorded for the MAR15-005-2 and MAR15-012-2 aqueous extracts revealed some degree of variation in their secondary metabolite spectroscopic profile (Figure 2b ). 
Conclusion
The results obtained from the biological screening of the nine sponge specimens (eight species) collected off the PEIs are exceptionally encouraging as the potential presence of cytotoxic secondary metabolites of three sponge specimens has been revealed. The similar cytotoxicity (EC 50 ~34 µg/mL; Table 1 ) of the organic sponge extracts MAR15-005-1 and MAR15-012-1 (collected at two different locations; Figure 1 ) against the A549 lung cancer cell line, coupled with their significantly congruent 1 H NMR profile (Figure 2a ), is very interesting as it suggests the possible presence of the same active molecule(s) from allopatric specimens of H. (H.) cf. panicea, that is, different specimens of the same species from different locations. However, the aqueous extracts prepared from the same two H. (H.) cf. panicea sponge specimens exhibit different cytotoxic (Table 1 ) and spectroscopic profiles (Figure 2b ), suggesting possible Marine sponges belonging to the genus Halichondria are known as producers of a wide range of bioactive secondary metabolites, including the well-known polyether macrolide class of highly cytotoxic compounds, such as the marine natural product Halichondrin B that showed excellent initial cancer cell toxicity and subsequently led to the development of the approved anti-cancer drug Halaven ® . 6, 7 Therefore, in our future work, we will aim to isolate and identify the cytotoxic compounds present in the two specimens of H. (H.) cf. panicea, as they could potentially be useful for further chemical and biological studies. The aqueous extract of the sponge Myxilla (Ectyomyxilla) kerguelensis (MAR15-001-2) displayed cytotoxic activity (EC 50 11.7 µg/mL; Table 1 ) against the HeLa cervical cancer cell line. A literature search revealed that the Marion Island sponge Myxilla (Ectyomyxilla) kerguelensis has not been extensively studied for its natural products chemistry composition and therefore presents us with a unique opportunity to address this knowledge gap. We have also recently extended our primary biological screening of these sponge extracts to include antiplasmodial and anti-tubercular bioassays, in which none of the extracts exhibited any activity. The results obtained in this study will now guide the purification, isolation and characterisation of the bioactive molecules responsible for the observed cytotoxicity against our panel of three cancer cell lines. Additionally, to supplement the paucity in biomass for the sponges collected during the 2015 expedition, more samples were collected from the same location on the recent 2016 survey to Marion Island and will be investigated in the same manner.
We highlight and acknowledge the various contributions from diverse scientific disciplines that have played a pivotal role in providing the necessary platform to enable this newly established marine biodiscovery effort to explore the natural products chemistry and biomedicinal value of marine sponges from the PEIs and Southern Ocean. We hope that our future collections of sponges and other marine invertebrates from the Southern Ocean will lead to the isolation and identification of highly potent cytotoxic marine natural product compounds such as Halichondrin B 6,7 , Cephalostatin 1 and Spongiostatin 4 9,10 , which have the potential to be further developed into anti-cancer agents. In our endeavour, we also hope to contribute to the understanding of the biodiversity and geographic distributions of these cold-water invertebrates.
